CENTER ID: | GilaA.18219.a |
ORGANISM: | Giardia lamblia ATCC 50803 |
ASSOCIATED DISEASE: | Giardiasis |
CURRENT STATUS: | purified |
COMMUNITY REQUEST: | True |
NIH RISK GROUP: | 2 |
SELECT AGENT: | False |
NIH PRIORITY pathogens category: |
IIIB |
CENTER REFERENCE ID |
DOMAIN/REGION DESCRIPTION |
INFO | AA START |
AA STOP |
ORDER MATERIAL |
---|---|---|---|---|---|
GilaA.18219.a.A3.GE44102 | truncation XtalPred disorder | 30 | 409 | ||
GilaA.18219.a.A6.GE44108 | truncation XtalPred disorder | 39 | 409 | ||
GilaA.18219.a.AE4.GE44105 | truncation XtalPred disorder | 33 | 409 |
RESOURCE | REFERENCE ID |
---|---|
EuPathDB: | GiardiaDB:GL50803_5772 |
UniProt: | A8B394 |
HARVESTED ON: | 3/2/2021 |
SEQUENCED ON: | 3/10/2021 |
EXPECTED MW: | 46kDa |
OBSERVED MW: | 46kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Low Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 89 |
PERCENT COVERAGE: | 86 |
HARVESTED ON: | 3/2/2021 |
SEQUENCED ON: | 3/10/2021 |
EXPECTED MW: | 45kDa |
OBSERVED MW: | 45kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Moderate Expression |
SOLUBLE EXPRESSION LEVEL | Low Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 98 |
PERCENT COVERAGE: | 100 |
HARVESTED ON: | 3/2/2021 |
SEQUENCED ON: | 3/10/2021 |
EXPECTED MW: | 44kDa |
OBSERVED MW: | 44kDa |
ANTIBIOTIC MARKER: | ampicillin |
COUNT OF EXPRESSION COLONIES: | Good (10-50) |
TOTAL EXPRESSION LEVEL: | Low Expression |
SOLUBLE EXPRESSION LEVEL | Low Expression |
EXPRESSION HOST: | BL 21 (DE3) Rosetta |
SEQUENCING RESULT: | |
PERCENT IDENTITY: | 85 |
PERCENT COVERAGE: | 87 |